Literature DB >> 24306080

Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.

Ascanio Tridente1, Geraldine M Clarke2, A Walden3, S McKechnie4, P Hutton4, G H Mills5, A C Gordon6, P A H Holloway6, J-D Chiche7, J Bion8, F Stuber9, C Garrard4, C J Hinds10.   

Abstract

INTRODUCTION: Faecal peritonitis (FP) is a common cause of sepsis and admission to the intensive care unit (ICU). The Genetics of Sepsis and Septic Shock in Europe (GenOSept) project is investigating the influence of genetic variation on the host response and outcomes in a large cohort of patients with sepsis admitted to ICUs across Europe. Here we report an epidemiological survey of the subset of patients with FP.
OBJECTIVES: To define the clinical characteristics, outcomes and risk factors for mortality in patients with FP admitted to ICUs across Europe.
METHODS: Data was extracted from electronic case report forms. Phenotypic data was recorded using a detailed, quality-assured clinical database. The primary outcome measure was 6-month mortality. Patients were followed for 6 months. Kaplan-Meier analysis was used to determine mortality rates. Cox proportional hazards regression analysis was employed to identify independent risk factors for mortality.
RESULTS: Data for 977 FP patients admitted to 102 centres across 16 countries between 29 September 2005 and 5 January 2011 was extracted. The median age was 69.2 years (IQR 58.3-77.1), with a male preponderance (54.3%). The most common causes of FP were perforated diverticular disease (32.1%) and surgical anastomotic breakdown (31.1%). The ICU mortality rate at 28 days was 19.1%, increasing to 31.6% at 6 months. The cause of FP, pre-existing co-morbidities and time from estimated onset of symptoms to surgery did not impact on survival. The strongest independent risk factors associated with an increased rate of death at 6 months included age, higher APACHE II score, acute renal and cardiovascular dysfunction within 1 week of admission to ICU, hypothermia, lower haematocrit and bradycardia on day 1 of ICU stay.
CONCLUSIONS: In this large cohort of patients admitted to European ICUs with FP the 6 month mortality was 31.6%. The most consistent predictors of mortality across all time points were increased age, development of acute renal dysfunction during the first week of admission, lower haematocrit and hypothermia on day 1 of ICU admission.

Entities:  

Mesh:

Year:  2013        PMID: 24306080     DOI: 10.1007/s00134-013-3158-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  35 in total

1.  Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection.

Authors:  T Koperna; F Schulz
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

Review 2.  The international sepsis forum consensus conference on definitions of infection in the intensive care unit.

Authors:  Thierry Calandra; Jonathan Cohen
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group.

Authors:  A Billing; D Fröhlich; F W Schildberg
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

5.  [The value of clinical parameters for determining the prognosis of peritonitis--validation of the Mannheim Peritonitis Index].

Authors:  N Demmel; K Maag; G Osterholzer
Journal:  Langenbecks Arch Chir       Date:  1994

6.  Sepsis in European intensive care units: results of the SOAP study.

Authors:  Jean-Louis Vincent; Yasser Sakr; Charles L Sprung; V Marco Ranieri; Konrad Reinhart; Herwig Gerlach; Rui Moreno; Jean Carlet; Jean-Roger Le Gall; Didier Payen
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

7.  Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial.

Authors:  Oddeke van Ruler; Cecilia W Mahler; Kimberly R Boer; E Ascelijn Reuland; Hein G Gooszen; Brent C Opmeer; Peter W de Graaf; Bas Lamme; Michael F Gerhards; E Philip Steller; J W Olivier van Till; Corianne J A M de Borgie; Dirk J Gouma; Johannes B Reitsma; Marja A Boermeester
Journal:  JAMA       Date:  2007-08-22       Impact factor: 56.272

8.  Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group.

Authors:  C Ohmann; D H Wittmann; H Wacha
Journal:  Eur J Surg       Date:  1993-05

9.  Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients.

Authors:  F Pacelli; G B Doglietto; S Alfieri; E Piccioni; A Sgadari; D Gui; F Crucitti
Journal:  Arch Surg       Date:  1996-06

10.  Preoperative predictors of mortality in adult patients with perforation peritonitis.

Authors:  Ranju Singh; Nishant Kumar; Abhijit Bhattacharya; Homay Vajifdar
Journal:  Indian J Crit Care Med       Date:  2011-07
View more
  23 in total

Review 1.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

2.  Effect of hypothermia on splenic leukocyte modulation and survival duration in severely septic rats.

Authors:  Rhett N Willis; Eric J Charles; Christopher A Guidry; Mahendra D Chordia; Stephen W Davies; Zequan Yang; Robert G Sawyer
Journal:  J Surg Res       Date:  2017-04-07       Impact factor: 2.192

3.  Therapeutic management of peritonitis: a comprehensive guide for intensivists.

Authors:  P Montravers; S Blot; G Dimopoulos; C Eckmann; P Eggimann; X Guirao; J A Paiva; G Sganga; J De Waele
Journal:  Intensive Care Med       Date:  2016-03-16       Impact factor: 17.440

4.  Variation of outcome and charges in operative management for diverticulitis.

Authors:  Hans F Fuchs; Ryan C Broderick; Cristina R Harnsberger; David C Chang; Elisabeth C Mclemore; Sonia Ramamoorthy; Santiago Horgan
Journal:  Surg Endosc       Date:  2014-12-25       Impact factor: 4.584

5.  Our paper 20 years later: 1-year survival and 6-month quality of life after intensive care.

Authors:  Maurizia Capuzzo; Margherita Bianconi
Journal:  Intensive Care Med       Date:  2015-01-21       Impact factor: 17.440

6.  Factors Predicting the Reversal of Hartmann's Procedure.

Authors:  Ömer Yalkın; Fatih Altıntoprak; Mustafa Yener Uzunoğlu; Yasin Alper Yıldız; Muhammet Burak Kamburoğlu; Necattin Fırat; Fehmi Çelebi
Journal:  Biomed Res Int       Date:  2022-07-04       Impact factor: 3.246

Review 7.  Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.

Authors:  Aprajita Jagpal; Jeffrey R Curtis
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

8.  Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia.

Authors:  Katie L Burnham; Emma E Davenport; Jayachandran Radhakrishnan; Peter Humburg; Anthony C Gordon; Paula Hutton; Eduardo Svoren-Jabalera; Christopher Garrard; Adrian V S Hill; Charles J Hinds; Julian C Knight
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

9.  Variants in the Mannose-binding Lectin Gene MBL2 do not Associate With Sepsis Susceptibility or Survival in a Large European Cohort.

Authors:  Tara C Mills; Stephen Chapman; Paula Hutton; Anthony C Gordon; Julian Bion; Jean-Daniel Chiche; Paul A H Holloway; Frank Stüber; Chris S Garrard; Charles J Hinds; Adrian V S Hill; Anna Rautanen
Journal:  Clin Infect Dis       Date:  2015-05-12       Impact factor: 9.079

10.  Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort.

Authors:  Ascanio Tridente; Geraldine M Clarke; Andrew Walden; Anthony C Gordon; Paula Hutton; Jean-Daniel Chiche; Paul A H Holloway; Gary H Mills; Julian Bion; Frank Stüber; Christopher Garrard; Charles Hinds
Journal:  Crit Care       Date:  2015-05-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.